ABSI 4.14 Absci Corporation
| Range: | 1.111-6.72 | Vol Avg: | 1014812 | Last Div: | 0 | Changes: | 0.28 |
| Beta: | 2.2 | Cap: | 0.46B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jul 22 2021 | Empoloyees: | 155 | ||
| CUSIP: | 00091E109 | CIK: | 0001672688 | ISIN: | US00091E1091 | Country: | US |
| CEO: | Mr. Sean McClain | Website: | https://www.absci.com | ||||
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow